Amnestic Disorders Therapeutics Market

Global Amnestic Disorders Therapeutics Market Size, Share: By Disease Type: Anterograde, Retrograde, Transient Global, Infantile Amnesia; By Drug Type; By Route of Administration; By Distributional Channel; By End User; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis; Competitive Landscape; 2024-2032

Global Amnestic Disorders Therapeutics Market Outlook

The global amnestic disorders therapeutics market is aided by the high diagnosis rate of the amnestic disorders. The market is expected to grow at a CAGR of 5% in the forecast period of 2024-2032.

 

Amnestic Disorders Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America is the Leading Market for Amnestic Disorders Therapeutics, Aided by the Developed Healthcare Infrastructure

Region-wise, North America is expected to be the leading market on the basis of revenue, followed by Europe. The two regions will continue being the leading markets within the industry, bolstered by the high disposable income and developed healthcare infrastructure. Furthermore, the Asia Pacific region is expected to be the fastest-growing market, owing to the significant opportunities in countries such as India and China. The region is further aided by the rising per capita incomes, expanding healthcare infrastructure, and increasing geriatric population.

 

Global Amnestic Disorders Therapeutics Market by End Use

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Amnestic Disorders Therapeutics: Market Segmentation

Amnestic disorders therapeutics are the treatment options of amnestic disorders, which is a category of disorders involving previously developed memory loss, loss of the ability to construct new memories, or loss of the ability to learn new knowledge.

On the basis of disease type, the industry is divided into:

  • Anterograde Amnesia 
  • Retrograde Amnesia 
  • Transient Global Amnesia 
  • Infantile Amnesia 
  • Others

Based on drug type, the industry can be segmented into:

  • Cholinesterase Inhibitors 
  • Memantine 
  • Others

Cholinesterase inhibitors are further divided into donepezil, rivastigmine, and galantamine, among others. The industry can be segmented on the basis of route of administration into oral and injectable.

On the basis of distribution channel, the industry is divided into hospital pharmacies, retail pharmacies, and online, among others. By end users, the industry is categorised into:

  • Hospitals
  • Special Clinics 
  • Home Care 
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Amnestic Disorders Therapeutics Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rising Geriatric Population to Aid the Global Amnestic Disorders Therapeutics Market Growth

The amnestic disorders therapeutics industry is being driven by the rising incidences of amnesia across the globe. This is further expected to grow in the forecast period, thus, further aiding the market growth. The rapidly growing geriatric population is also expected to bolster the industry. The amnestic disorders therapeutics industry is further enhanced by the high diagnosis rate, favourable reimbursement scenario, high disposable incomes, availability of a large number of hospitals, and a well-developed healthcare infrastructure in developed regions, such as North America and Europe. In the coming years, the rising R&D investments are expected to aid the growth of the industry further.

 

Key Industry Players in the Global Amnestic Disorders Therapeutics Market

The report gives a detailed analysis of the following key players in the global amnestic disorders therapeutics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Eisai Co., Ltd.  
  • AbbVie Inc 
  • Novartis AG 
  • Johnson & Johnson Services, Inc. 
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Disease Type, Drug Type, Route of Administration, Distributional Channel, End User, Region
Breakup by Disease Type Anterograde Amnesia, Retrograde Amnesia, Transient Global Amnesia, Infantile Amnesia, Others
Breakup by Drug Type Cholinesterase Inhibitors, Memantine, Others
Breakup by Route of Administration Oral, Injectable
Breakup by Distributional Channel Hospital Pharmacies, Retail Pharmacies, Online, Others
Breakup by End User Hospitals, Special Clinics, Home Care, Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Eisai Co., Ltd., AbbVie Inc, Novartis AG, Johnson & Johnson Services, Inc., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Amnestic Disorders Therapeutics Market Analysis
    8.1    Key Industry Highlights
    8.2    Global Amnestic Disorders Therapeutics Historical Market (2018-2023) 
    8.3    Global Amnestic Disorders Therapeutics Market Forecast (2024-2032)
    8.4    Global Amnestic Disorders Therapeutics Market by Disease Type
        8.4.1    Anterograde Amnesia
            8.4.1.1    Historical Trend (2018-2023)
            8.4.1.2    Forecast Trend (2024-2032)
        8.4.2    Retrograde Amnesia
            8.4.2.1    Historical Trend (2018-2023)
            8.4.2.2    Forecast Trend (2024-2032)
        8.4.3    Transient Global Amnesia
            8.4.3.1    Historical Trend (2018-2023)
            8.4.3.2    Forecast Trend (2024-2032)
        8.4.4    Infantile Amnesia
            8.4.4.1    Historical Trend (2018-2023)
            8.4.4.2    Forecast Trend (2024-2032)
        8.4.5    Others
    8.5    Global Amnestic Disorders Therapeutics Market by Drug Type
        8.5.1    Cholinesterase Inhibitors
                8.5.1.1    Historical Trend (2018-2023)
                8.5.1.2    Forecast Trend (2024-2032)
                8.5.1.3    Breakup by Type
                    8.5.1.3.1    Donepezil
                        8.5.1.3.1.1    Historical Trend (2018-2023)
                        8.5.1.3.1.2    Forecast Trend (2024-2032)
                    8.5.1.3.2    Rivastigmine
                        8.5.1.3.2.1    Historical Trend (2018-2023)
                        8.5.1.3.2.2    Forecast Trend (2024-2032)
                    8.5.1.3.3    Galantamine
                        8.5.1.3.3.1    Historical Trend (2018-2023)
                        8.5.1.3.3.2    Forecast Trend (2024-2032)
                    8.5.1.3.4    Others
        8.5.2    Memantine
            8.5.2.1    Historical Trend (2018-2023)
            8.5.2.2    Forecast Trend (2024-2032)
        8.5.3    Others
    8.6    Global Amnestic Disorders Therapeutics Market by Route of Administration
        8.6.1    Oral
            8.6.1.1    Historical Trend (2018-2023)
            8.6.1.2    Forecast Trend (2024-2032)
        8.6.2    Injectable
            8.6.2.1    Historical Trend (2018-2023)
            8.6.2.2    Forecast Trend (2024-2032)
    8.7    Global Amnestic Disorders Therapeutics Market by Distributional Channel
        8.7.1    Hospital Pharmacies
            8.7.1.1    Historical Trend (2018-2023)
            8.7.1.2    Forecast Trend (2024-2032)
        8.7.2    Retail Pharmacies
            8.7.2.1    Historical Trend (2018-2023)
            8.7.2.2    Forecast Trend (2024-2032)
        8.7.3    Online
            8.7.3.1    Historical Trend (2018-2023)
            8.7.3.2    Forecast Trend (2024-2032)
        8.7.4    Others
    8.8    Global Amnestic Disorders Therapeutics Market by End User
        8.8.1    Hospitals
            8.8.1.1    Historical Trend (2018-2023)
            8.8.1.2    Forecast Trend (2024-2032)
        8.8.2    Special Clinics
            8.8.2.1    Historical Trend (2018-2023)
            8.8.2.2    Forecast Trend (2024-2032)
        8.8.3    Home Care
            8.8.3.1    Historical Trend (2018-2023)
            8.8.3.2    Forecast Trend (2024-2032)
        8.8.4    Others
    8.9    Global Amnestic Disorders Therapeutics Market by Region       
        8.9.1    North America
            8.9.1.1    Historical Trend (2018-2023) 
            8.9.1.2    Forecast Trend (2024-2032)
        8.9.2    Europe
            8.9.2.1    Historical Trend (2018-2023) 
            8.9.2.2    Forecast Trend (2024-2032)
        8.9.3    Asia Pacific
            8.9.3.1    Historical Trend (2018-2023) 
            8.9.3.2    Forecast Trend (2024-2032)
        8.9.4    Latin America
            8.9.4.1    Historical Trend (2018-2023) 
            8.9.4.2    Forecast Trend (2024-2032)
        8.9.5    Middle East and Africa
            8.9.5.1    Historical Trend (2018-2023) 
            8.9.5.2    Forecast Trend (2024-2032) 
9    North America Amnestic Disorders Therapeutics Market Analysis
    9.1    United States of America 
        9.1.1    Historical Trend (2018-2023) 
        9.1.2    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Historical Trend (2018-2023) 
        9.2.2    Forecast Trend (2024-2032)
10    Europe Amnestic Disorders Therapeutics Market Analysis
    10.1    United Kingdom
        10.1.1    Historical Trend (2018-2023) 
        10.1.2    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Historical Trend (2018-2023) 
        10.2.2    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Historical Trend (2018-2023) 
        10.3.2    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Historical Trend (2018-2023) 
        10.4.2    Forecast Trend (2024-2032)
    10.5    Others
11    Asia Pacific Amnestic Disorders Therapeutics Market Analysis
    11.1    China
        11.1.1    Historical Trend (2018-2023) 
        11.1.2    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Historical Trend (2018-2023) 
        11.2.2    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Historical Trend (2018-2023) 
        11.3.2    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Historical Trend (2018-2023) 
        11.4.2    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.1    Historical Trend (2018-2023) 
        11.5.2    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America Amnestic Disorders Therapeutics Market Analysis
    12.1    Brazil
        12.1.1    Historical Trend (2018-2023) 
        12.1.2    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Historical Trend (2018-2023) 
        12.2.2    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Historical Trend (2018-2023) 
        12.3.2    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and Africa  Amnestic Disorders Therapeutics Market Analysis
    13.1    Saudi Arabia
        13.1.1    Historical Trend (2018-2023) 
        13.1.2    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Historical Trend (2018-2023) 
        13.2.2    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Historical Trend (2018-2023) 
        13.3.2    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Historical Trend (2018-2023) 
        13.4.2    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Value Chain Analysis
16    Competitive Landscape

    16.1    Market Structure
    16.2    Company Profiles
        16.2.1    Eisai Co., Ltd. 
            16.2.1.1    Company Overview
            16.2.1.2    Product Portfolio
            16.2.1.3    Demographic Reach and Achievements
            16.2.1.4    Certifications
        16.2.2    AbbVie Inc
            16.2.2.1    Company Overview
            16.2.2.2    Product Portfolio
            16.2.2.3    Demographic Reach and Achievements
            16.2.2.4    Certifications
        16.2.3    Novartis AG
            16.2.3.1    Company Overview
            16.2.3.2    Product Portfolio
            16.2.3.3    Demographic Reach and Achievements
            16.2.3.4    Certifications
        16.2.4    Johnson & Johnson Services, Inc.
            16.2.4.1    Company Overview
            16.2.4.2    Product Portfolio
            16.2.4.3    Demographic Reach and Achievements
            16.2.4.4    Certifications
        16.2.5    Others
17    Key Trends and Developments in the Market


List of Key Figures and Tables

1.    Global Amnestic Disorders Therapeutics Market: Key Industry Highlights, 2018 and 2032
2.    Global Amnestic Disorders Therapeutics Historical Market: Breakup by Disease Type (USD Billion), 2018-2023
3.    Global Amnestic Disorders Therapeutics Market Forecast: Breakup by Disease Type (USD Billion), 2024-2032
4.    Global Amnestic Disorders Therapeutics Historical Market: Breakup by Drug Type (USD Billion), 2018-2023
5.    Global Amnestic Disorders Therapeutics Market Forecast: Breakup by Drug Type (USD Billion), 2024-2032
6.    Global Amnestic Disorders Therapeutics Historical Market: Breakup by Route of Administration (USD Billion), 2018-2023
7.    Global Amnestic Disorders Therapeutics Market Forecast: Breakup by Route of Administration (USD Billion), 2024-2032
8.    Global Amnestic Disorders Therapeutics Historical Market: Breakup by Distributional Channel (USD Billion), 2018-2023
9.    Global Amnestic Disorders Therapeutics Market Forecast: Breakup by Distributional Channel (USD Billion), 2024-2032
10.    Global Amnestic Disorders Therapeutics Historical Market: Breakup by End User (USD Billion), 2018-2023
11.    Global Amnestic Disorders Therapeutics Market Forecast: Breakup by End User (USD Billion), 2024-2032
12.    Global Amnestic Disorders Therapeutics Historical Market: Breakup by Region (USD Billion), 2018-2023
13.    Global Amnestic Disorders Therapeutics Market Forecast: Breakup by Region (USD Billion), 2024-2032
14.    North America Amnestic Disorders Therapeutics Historical Market: Breakup by Country (USD Billion), 2018-2023
15.    North America Amnestic Disorders Therapeutics Market Forecast: Breakup by Country (USD Billion), 2024-2032
16.    Europe Amnestic Disorders Therapeutics Historical Market: Breakup by Country (USD Billion), 2018-2023
17.    Europe Amnestic Disorders Therapeutics Market Forecast: Breakup by Country (USD Billion), 2024-2032
18.    Asia Pacific Amnestic Disorders Therapeutics Historical Market: Breakup by Country (USD Billion), 2018-2023
19.    Asia Pacific Amnestic Disorders Therapeutics Market Forecast: Breakup by Country (USD Billion), 2024-2032
20.    Latin America Amnestic Disorders Therapeutics Historical Market: Breakup by Country (USD Billion), 2018-2023
21.    Latin America Amnestic Disorders Therapeutics Market Forecast: Breakup by Country (USD Billion), 2024-2032
22.    Middle East and Africa Amnestic Disorders Therapeutics Historical Market: Breakup by Country (USD Billion), 2018-2023
23.    Middle East and Africa Amnestic Disorders Therapeutics Market Forecast: Breakup by Country (USD Billion), 2024-2032
24.    Global Amnestic Disorders Therapeutics Market Structure

Key Questions Answered in the Report

The market is projected to grow at a CAGR of 5% between 2024 and 2032.

The major drivers of the industry, such as rising disposable incomes, developing healthcare infrastructure, growing geriatric population, and increasing incidences of amnesia, are expected to aid the market growth.

The key trends guiding the growth of the market include the growing R&D investments in developing treatment options for amnesia.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest market share.

The leading disease types in the industry are anterograde, retrograde, transient global, and infantile amnesia, among others.

The major drug types in the industry are cholinesterase inhibitors and memantine.

The significant routes of administration in the market are oral and injectable.

The leading distribution channels in the industry are hospital pharmacies, retail pharmacies, and online, among others.

The major end-users in the market are hospitals, special clinics, and home care, among others.

The major players in the industry are Eisai Co., Ltd., AbbVie Inc, Novartis AG, and Johnson & Johnson Services, Inc., among others.

Analyst Review

The global amnestic disorders therapeutics market is being driven by the rising prevalence of amnesia. Aided by the growing R&D investments, the market is expected to witness a moderate growth in the forecast period of 2024-2032, growing at a CAGR of 5%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on disease types, the market is segmented into anterograde, retrograde, transient global, and infantile amnesia, among others. On the basis of drug type, the industry is divided into cholinesterase inhibitors and memantine. By route of administration, the market is bifurcated into oral and injectable. Based on distribution channel, the industry is segmented into hospital pharmacies, retail pharmacies, and online, among others. On the basis of end-users, the market is divided into hospitals, special clinics, and home care, among others. The major regional markets for amnestic disorders therapeutics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest share of the market. The key players in the above market include Eisai Co., Ltd., AbbVie Inc, Novartis AG, and Johnson & Johnson Services, Inc., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2799
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER